Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo

Obesity

Volumn 19, Issue 5, 2011, Pages 903-910

  White, Ursula A ^a   Stewart, William C ^b   Stephens, Jacqueline M ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b MIDDLE TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTROPHIN 1; GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; ONCOSTATIN M; STAT3 PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GLUCOSE TRANSPORT; HEMATOPOIESIS; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CYTOKINE RECEPTOR GP130; CYTOKINES; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-11; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MICE; ONCOSTATIN M; RATS; RECEPTOR CROSS-TALK; RECEPTORS, OSM-LIF; RNA, MESSENGER; SIGNAL TRANSDUCTION;

MURINAE;

EID: 79955474127     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.293     Document Type: Article

References (40)

1. Fasnacht N, Müller W. Conditional gp130 deficient mouse mutants. Semin Cell Dev Biol 2008;19:379-384.
2. Heinrich PC, Behrmann I, Haan S et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003;374:1-20. (Pubitemid 37046923)
3. Febbraio MA. gp130 receptor ligands as potential therapeutic targets for obesity. J Clin Invest 2007;117:841-849. (Pubitemid 46556736)
4. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997;15:797-819. (Pubitemid 27169299)
5. Taga T, Hibi M, Hirata Y et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989;58:573-581. (Pubitemid 19203542)
6. Hilton DJ, Hilton AA, Raicevic A et al. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J 1994;13:4765-4775. (Pubitemid 24319358)
7. Pflanz S, Hibbert L, Mattson J et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004;172:2225-2231. (Pubitemid 38182370)
8. Gearing D P, Thut CJ, VandeBos T et al. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J 1991;10: 2839-2848. (Pubitemid 21905301)
9. Pennica D, Shaw KJ, Swanson TA et al. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem 1995;270:10915-10922.
10. Robledo O, Guillet C, Chevalier S et al. Hepatocyte-derived cell lines express a functional receptor for cardiotrophin-1. Eur Cytokine Netw 1997;8:245-252. (Pubitemid 27470093)
11. Ichihara M, Hara T, Kim H, Murate T, Miyajima A. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood 1997;90:165-173. (Pubitemid 27276559)
12. Gearing D P, Comeau MR, Friend DJ et al. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992;255:1434-1437.
13. Davis S, Aldrich TH, Stahl N et al. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 1993;260: 1805-1808. (Pubitemid 23244206)
14. Elson GC, Lelièvre E, Guillet C et al. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci 2000;3:867-872.
15. Derouet D, Rousseau F, Alfonsi F et al. Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. Proc Natl Acad Sci USA 2004;101:4827-4832. (Pubitemid 38469162)
16. White UA, Stephens JM. Neuropoietin activates STAT3 independent of LIFR activation in adipocytes. Biochem Biophys Res Commun 2010;395:48-50.
17. Balhoff J P, Stephens JM. Highly specific and quantitative activation of STATs in 3T3-L1 adipocytes. Biochem Biophys Res Commun 1998;247:894-900. (Pubitemid 28418487)
18. Tenney R, Stansfield K, Pekala PH. Interleukin 11 signaling in 3T3-L1 adipocytes. J Cell Physiol 2005;202:160-166. (Pubitemid 39603373)
19. Stephens JM, Lumpkin SJ, Fishman JB. Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes. J Biol Chem 1998;273: 31408-31416. (Pubitemid 28533160)
20. Zvonic S, Cornelius P, Stewart WC, Mynatt RL, Stephens JM. The regulation and activation of ciliary neurotrophic factor signaling proteins in adipocytes. J Biol Chem 2003;278:2228-2235. (Pubitemid 36801290)
21. Zvonic S, Hogan JC, Arbour-Reily P, Mynatt RL, Stephens JM. Effects of cardiotrophin on adipocytes. J Biol Chem 2004;279:47572-47579. (Pubitemid 39540902)
22. White UA, Stewart WC, Mynatt RL, Stephens JM. Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes. J Biol Chem 2008;283:22505-22512.
23. Miyaoka Y, Tanaka M, Naiki T, Miyajima A. Oncostatin M inhibits adipogenesis through the RAS/ERK and STAT5 signaling pathways. J Biol Chem 2006;281: 37913-37920. (Pubitemid 46042095)
24. Song HY, Jeon ES, Kim JI, Jung JS, Kim JH. Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 2007;101: 1238-1251.
25. Hogan JC, Stephens JM. Effects of leukemia inhibitory factor on 3T3-L1 adipocytes. J Endocrinol 2005;185:485-496. (Pubitemid 40883394)
26. Zvonic S, Baugh JE Jr, Arbour-Reily P, Mynatt RL, Stephens JM. Crosstalk among gp130 cytokines in adipocytes. J Biol Chem 2005;280: 33856-33863.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
28. Malavazos AE, Ermetici F, Morricone L et al. Association of increased plasma cardiotrophin-1 with left ventricular mass indexes in normotensive morbid obesity. Hypertension 2008;51:e8-9; author reply e10. (Pubitemid 351159961)
29. Natal C, Fortuño MA, Restituto P et al. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am J Physiol Endocrinol Metab 2008;294:E52-E60.
30. Hirota H, Izumi M, Hamaguchi T et al. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure. Heart Vessels 2004;19:237-241. (Pubitemid 39335083)
31. Pradeep AR, S TM, Garima G, Raju A. Serum levels of oncostatin M (a gp 130 cytokine): an inflammatory biomarker in periodontal disease. Biomarkers 2010;15:277-282.
32. Hansen D, Dendale P, Beelen M et al. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Eur J Appl Physiol 2010;109:397-404.
33. Heizmann O, Koeller M, Muhr G, Oertli D, Schinkel C. Th1- and Th2-type cytokines in plasma after major trauma. J Trauma 2008;65:1374-1378.
34. Miyagaki T, Sugaya M, Shibata S et al. Serum interleukin-27 levels in patients with cutaneous T-cell lymphoma. Clin Exp Dermatol 2010;35:e143-e144.
35. Blanchard F, Duplomb L, Wang Y et al. Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem 2000;275:28793-28801.
36. Blanchard F, Wang Y, Kinzie E et al. Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. J Biol Chem 2001; 276:47038-47045.
37. Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 2008;19:414-422.
38. Stross C, Radtke S, Clahsen T et al. Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism. J Biol Chem 2006;281:8458-8468. (Pubitemid 43847948)
39. Gnacinska M, Malgorzewicz S, Guzek M, Lysiak-Szydlowska W, Sworczak K. Adipose tissue activity in relation to overweight or obesity. Endokrynol Pol 2010;61:160-168.
40. Khaodhiar L, Ling PR, Blackburn GL, Bistrian BR. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enteral Nutr 2004;28:410-415. (Pubitemid 39463824)